收藏切换
Safety analysis and selection of excipients for intrathecal drugs
收藏切换
Xia ZHANG, Shang-chen YAO, Bao-ming NING, Jin LI*, Hui-min SUN*
Chinese Journal of New Drugs | 2026, 35(14) : 1457 - 1463
Less
收藏切换
Chinese Journal of New Drugs | 2026, 35(14): 1457-1463
Safety analysis and selection of excipients for intrathecal drugs
Full
Xia ZHANG, Shang-chen YAO, Bao-ming NING, Jin LI*, Hui-min SUN*
Affiliations
  • National Institutes for Food and Drug Control, Beijing 102629, China
Published: 2026-07-30 doi: 10.20251/j.cnki.1003-3734.2026.14.001
Outline
收藏切换
Objective:

To prevent and control the risk of excipients in intrathecal drugs and strengthen their management.

Methods:

Information of excipients in approved intrathecal drugs abroad was collected, the quality requirements of regulatory agencies for intrathecal drugs in various countries were listed, literature on the safety of excipients in intrathecal drugs was searched and sorted out, and the impact of intrathecal drugs on medication safety was analyzed.

Results:

The quality requirements for intrathecal drugs are stricter than those for ordinary injections, with fewer types and quantities of excipients. Regulatory agencies in various countries specified that intrathecal drugs must not contain preservatives, and the threshold of bacterial endotoxin per kg of body mass in a single hour period is much lower than that for ordinary injections. The information on excipients for intrathecal drugs in the US "Inactive Ingredient Search for Approved Drug Products" is an important reference for excipient selection during formulation development.

Conclusion:

The safety and regulation of excipients in intrathecal injections are critical to ensuring the clinical safety of these high-risk formulations. It is recommended that drug regulatory agencies, research and development departments, and manufacturing enterprises collectively enhance their attention to the excipients used in intrathecal injections. By improving the regulatory framework, promoting safety research, and strengthening lifecycle management, the risk associated with excipients can be systematically assessed and controlled, thereby better safeguarding patient medication safety.

intrathecal drugs  /  excipients  /  preservatives  /  neurotoxicity  /  bacterial endotoxins  /  adverse reactions  /  pharmaceutical excipients regulation
张夏, 姚尚辰, 宁保明, 李进, 孙会敏. 鞘内注射剂中药用辅料的安全性分析与选择. 中国新药杂志, 2026 , 35 (14) : 1457 -1463 . DOI: 10.20251/j.cnki.1003-3734.2026.14.001
Xia ZHANG, Shang-chen YAO, Bao-ming NING, Jin LI, Hui-min SUN. Safety analysis and selection of excipients for intrathecal drugs[J]. Chinese Journal of New Drugs, 2026 , 35 (14) : 1457 -1463 . DOI: 10.20251/j.cnki.1003-3734.2026.14.001
Year 2026 volume 35 Issue 14
46
10
Cite this Article
BibTeX
Article Info
doi: 10.20251/j.cnki.1003-3734.2026.14.001
  • Online Date:2026-10-26
  • Published:2026-07-30
Article Data
Affiliations
History
  • Accepted:2025-11-23
Affiliations
    National Institutes for Food and Drug Control, Beijing 102629, China
References
Share
https://castjournals.cast.org.cn/joweb/zgxyzz/EN/10.20251/j.cnki.1003-3734.2026.14.001
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT